Johns Hopkins University Launches Online Course to Train “Ambassadors” to Convince Parents to Inoculate Their Children

Johns Hopkins University launched an online course in January 2022 that trains “vaccine ambassadors” to convince their peers to inoculate their young children with the experimental COVID-19 injection. 

Children have the lowest risk of severe COVID-19 complications, yet Johns Hopkins seeks to prey on “vaccine-hesitant” parents to inject every kid with a dangerous mRNA gene therapy. 

The online course published by the Johns Hopkins Bloomberg School of Public Health (JH) and titled “COVID Vaccine Ambassador Training: How to Talk to Parents” dismisses legitimate criticisms of the experimental shot as misinformation or “fake news.”

The university claims there’s no legitimate basis in declining the “free” injection for themselves or their children. The new course is the latest offering of the May 2020 initiative that began with a contact tracing course that enrolled 1.3 million individuals. 

Although healthy children have the highest survival rate, the course description fearmongers prospective ambassadors with misleading figures of child COVID hospitalizations. 

And Johns Hopkins makes the ridiculous claim that the experimental COVID-19 jabs save lives and prevent serious illness in children.  

Johns Hopkins has launched a new 2-hour online course aimed to train “vaccine ambassadors” to talk to concerned parents and guardians who might have apprehensions regarding COVID-19 vaccines for their school-age children. https://t.co/9t4KggQbK1

— WMAR-2 News (@WMAR2News) January 22, 2022

Johns Hopkins Launches Free Course To Train 'Ambassadors' For Children's COVID-19 Vaccine https://t.co/E27ivN9bJ7 pic.twitter.com/eKKOG7to5k

— WJZ | CBS Baltimore (@wjz) January 20, 2022

As described by Johns Hopkins:

The goal of the course is to empower more people to communicate with parents in the U.S. who have concerns about vaccinating their children, despite the availability of safe, effective, and free COVID-19 vaccines for children ages five and up. In recent weeks, COVID-19 hospitalizations in children have spiked to record levels, including among unvaccinated children ages 5 and up who are eligible for COVID-19 vaccines. According to the Centers for Disease Control and Prevention, an average of 672 children age 17 and under were admitted to hospitals every day with COVID-19 during the week ending Sunday, January 2—the highest such number of the pandemic. These numbers underscore the urgency to get eligible children across the country vaccinated and boosted now.

At the same time, teachers, school administrators and staff, PTAs, and parents have expressed interest in learning how to effectively communicate and engage in conversations about vaccine hesitancy with members of their community. This course is designed to teach adults how to have respectful and empathetic conversations with parents and guardians who remain hesitant about vaccination for their children, even if they are vaccinated themselves.

“Having conversations about COVID-19 vaccinations, can, at times, feel uncomfortable, especially if parents don’t see eye to eye or the conversation turns political, but we need to have this kind of dialogue with one another if we’re going to move forward in this pandemic and begin to address vaccine hesitancy,” said Rupali Limaye, PhD, MPH, director of Behavioral and Implementation Science at the Bloomberg School’s International Vaccine Access Center. “While these vaccines work, unless children and their parents feel confident pursuing them, we’ll continue to see COVID-19 infections, hospitalizations, and death rates go up.”

LifeSiteNews noted the funding behind the initiative:

The COVID-19 vaccine craze has been a huge money-maker for the pharmaceutical industry and now, with JH’s help, Big-Pharma seeks to enlist an army of grassroots volunteers to strong-arm 5-year-olds into becoming a new revenue source.

Unsurprisingly, Pfizer, maker of one of the leading COVID-19 vaccines, is a major donor to Johns Hopkins Drug Discovery Program. In all, 19 pharmaceutical companies provide funding for JH’s research.

Also unsurprisingly, the Pfizer-BioNTech COVID-19 vaccine is the only one that has been granted approval to be administered to children ages 5 years old and up, and the pharmaceutical behemoth has just announced that it’s actively seeking approval for a COVID-19 vaccine for babies as young as just 6 months old.

The Johns Hopkins-Pfizer connection raises important questions about the content of the COVID Vaccine Ambassador Training course and the motivation driving the campaign to vaccinate kids, the demographic least likely to be harmed by the virus.